Turtle Creek Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Turtle Creek Wealth Advisors's XBI Position: Q2 2026 in Review
Turtle Creek Wealth Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 121% in Q2 2026, buying an estimated $205K and bringing the position to 2,776 shares worth $439K. The position accounts for 0.02% of the portfolio, ranked #283.
Turtle Creek Wealth Advisors first reported a position in XBI in Q1 2026 and has held it in 2 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Turtle Creek Wealth Advisors held 2,776 shares of State Street SPDR S&P Biotech ETF worth $439K as of Q2 2026.
- Turtle Creek Wealth Advisors bought 1,520 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $205K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #283 holding.
- Turtle Creek Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 2 quarters since.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.